1) Targets Fat Metabolism (AOD 9604) Supports pathways commonly associated with: fat breakdown stubborn fat reduction support lean tissue protection during dieting 2) Supports Energy + Metabolic Flexibility (MOTS-c) Supports: mitochondrial energy production better fuel utilization (carbs + fats) metabolic resilience during stress, dieting, or busy seasons 3) Supports Visceral Fat + Midsection Goals (Tesamorelin) Supports: visceral fat reduction in certain individuals midsection-focused body composition goals metabolic pathway support under provider guidance 4) Supports Recovery + Sleep (Ipamorelin) Supports: deeper, more restorative sleep better recovery between workouts improved consistency (because you feel better while leaning out) In simple terms: AOD + MOTS-c help the metabolism feel on, Tesamorelin supports midsection/visceral fat goals, and Ipamorelin helps you recover and sleep so you can stay consistent
However, there are more stringent rules (rules that must be followed carefully without exceptions) for insulin-dependent Type 1 diabetics
Pugliese G, Penno G, Natali A, Barutta F, Di Paolo S, Reboldi G, Gesualdo L, De Nicola L, Italian Diabetes Society and the Italian Society of Nephrology
Consistent with these clinical trials, several recent studies have reported that DPP-4i can alleviate hypertensive conditions in animal models (1519)
Yet not one of them went through long-term trials to determine whether or not they would be safe for a lifetime
Chris Snyder: The number one, you know, metric I think the market looks at is manufacturing project starts
